Publikationen, an denen er mitarbeitet Eduardo Díaz-Rubio García (7)

1998

  1. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

    Annals of Oncology, Vol. 9, Núm. 7, pp. 727-731

1996

  1. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial

    Annals of Oncology, Vol. 7, Núm. 6, pp. 581-585

  2. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).

    The Journal of infusional chemotherapy, Vol. 6, Núm. 3, pp. 118-122

1995

  1. A phase II trial of weekly high dose continuous infusion 5‐fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

    Cancer, Vol. 76, Núm. 4, pp. 559-563

1994

  1. ESTUDIO CON REPARTO ALEATORIO DE NAVELBINA FRENTE A NAVELBINA Y CISPLATINO FRENTE A VINDESINA Y CISPLATINO EN EL TRATAMIENTO DEL CARCINOMA PULMONAR NO MICROCELULAR INOPERABLE. RESULTADOS DE UN ESTUDIO MULTICENTRICO EUROPEO INCLUYENDO 612 PACIENTES

    Revista Clinica Espanola, Vol. 194, Núm. 11, pp. 953-959

1992

  1. A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.)

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 15, Núm. 1, pp. 56-60

  2. Etoposide (E) + epirebicin (E) + cisplatin (P) combination chemotherapy (EEP) In advanced gastric cancer: Negative impact on clinical outcome: On behalf of the Spanish cooperative group for GI tumor therapy (T.T.D.)

    Annals of Oncology, Vol. 3, Núm. 10, pp. 861-863